Nosocomial Infection

Vexing Critical Care Challenges - Clostridium difficile Colitis - WEBCAST

This Webcast is designed to provide intensive care unit (ICU) clinicians and hospital personnel with information related to the increased incidence of Clostridium difficile colitis in the ICU as well as risk factors and prevention strategies. Initial treatment procedures for the patient with C. difficile colitis and refractory cases will be identified. Emphasis will be placed on infection control as a method of prevention, pharmacologic treatment methodologies, and patient and staff safety issues.

View PPT Presentations:
     CDI in the ICU - Dr. Olsen
     Managing CDI - Dr. Owens

Central Line Infections - WEBCAST

This Webcast is designed to provide clinicians with information related to the best practice methods for inserting and maintaining the central line catheter in the the Adult ICU patient.  Presenters provide information on the best practice methods used to reduce central line infection rates to maximize achievement of a zero infection rate.  Information pertaining to the new guideline development was also included in this presentation.

Watch Video Presentation

ICU Infection in an Era of Multi-Resistance
Joint SCCM-ESICM Summer 2009 Conference

The ICU Infection in an Era of Multi-Resistance is now available for online viewing.  In order to view this free conference, you will need to register for the program. Once registered, you will receive an email containing your login ID and password, which can be used to log on to the course through the MySCCM page.

Click here to register and watch the conference.

Program Objectives:

At the conclusion of the Antibiotic-Resistant Infection program, the participants will be able to:

1. List methods/strategies for identifying patients (e.g., trauma, transplant, elderly, diabetic, etc.) with a potential risk for contracting antibiotic-resistant infections.
2. Identify appropriate drugs or drug/therapy combinations for combating antibiotic-resistant infections based on the type of infection and pre-existing disease processes.
3. Discuss infectious disease guidelines for the control and/or prevention of infections such as Ventilator-Associated Pneumonia, Methicillin-resistant Staphylococcus aureus, Clostridium difficile, and others.
4. Evaluate hospital and ICU team management strategies for superbugs and foreseeable antibiotic-resistant infections of the future.

Content and Presenters:

• Who's at Risk for Infection
• Identifying the Patient at Risk for Antibiotic-Resistant Infections/Pathogens - Randy Wax, MD
• Special Risks for Transplant Patients - Mira Loh-trivedi, PharmD
• Special Risks for Burn and Critically Injured ICU Patients - Robert Sawyer, MD
• Emerging Immunocompromised Host - Jean-Daniel Chiche, MD
• The Right Drug for the Right Infection - Naomi O'Grady, MD
• What Epidemics Have Taught Us - Randy Wax, MD
• Isolation - Does it prevent cross-Contamination? Does it Help the Patient?
• Pro side: Marc Bonton, MD
• Con side: Naomi O'Grady, MD
• Fundamentals of Dealing with Flu Epidemics - Randy Wax, MD
• Fungal Infections in the ICU - Pam Lipsett, MD FCCM
• Break Out Sessions:
• Is Vancomycin-Resistant Enterococucus (VRE) Under Control? - Gourang P. Patel, PharmD
• Acinetobacter Baumanii - What are the Options?  Enterobacteriaceae (ESBL) - How to Treat? - George Dimopoulos, MD
• Antibiotics in Pancreatitis Patients
• Pro side: Pam Lipsett, MD FCCM
• Con side: Claude Martin, MD
• Postoperative Necrotizing Fasciitis and Surgery-Associated Infections - Robert Sawyer, MD
• Ventilator-Associated Pneumonia (VAP)
• Preventing VAP: Opportunity for Interventions - Marc Bonton, MD
• Guidelines for Management - Marin Kollef, MD
• What is the Future of Methicillin-Resistant Staphylococcus Aureus? (MRSA) - Marin Kollef, MD
• Cocktails Anyone?  Antibiotic Combinations
• Pro side: Scott Micek, PharmD
• Con side: Claude Martin, MD
• Antibiotic-Resistant Infections: Who Pays? - Marc Bonton, MD
• Antibiotics - What's in the Future? - Scott Micek, PharmD
• Dealing with Multi-Drug-Resistant Gram-Negative Organisms - George Dimopoulos, MD

CE: No CE credit is associated with this content

Conference Registration:

In order to view this free conference, you will need to register for the program. Once registered, you will receive an email containing your login ID and password, which can be used to log on to the course through the MySCCM page.

Click here to register and watch the conference.

Disclaimer:

The views expressed herein are those of the presenter(s) and do not necessarily reflect the views of the Society of Critical Care Medicine. Use of trade names or names of commercial sources is for information only and does not imply endorsement by the Society of Critical Care Medicine. This presentation is intended to provide accurate information regarding the subject matter addressed herein. However, it is made available with the understanding that the Society of Critical Care Medicine is not engaged in the rendering of medical, legal, financial, accounting, or other professional service.

The information in this presentation is subject to change at any time without notice and should not be relied upon as a substitute for professional advice from an experienced, competent practitioner in the relevant field. Neither the Society of Critical Care Medicine, nor the presenter(s), makes any guarantees or warranties concerning the information contained herein. If expert assistance is required, please seek the services of an experienced, competent professional in the relevant field. Accurate indications, adverse reactions, and dosage schedules for drugs may be provided in this text, but it is possible that they may change. Users are urged to review current package indications and usage guidelines provided by the manufacturers of the agents mentioned.

37th Critical Care Congress: An Erupting Landscape: Nosocomial Pneumonia in the Age of Resistance
Supported by an educational grant from Ortho McNeil

• Michael S. Niederman, MD, FCCM, discusses emerging epidemiological trends among nosocomial gram-negative bacilli
• David Nicolau PharmD presents the rationale of antimicrobial dosing strategies to optimize clinical outcomes and prevent resistance development
• Donald E. Craven, MD Identifies viable therapeutic options for these difficult-to-treat infections

36th Critical Care Congress: The Latest in Nosocomial Infections

• Marin Kollef, MD, discusses ventilator-associated pneumonia (VAP) and various prevention techniques such as coated endotracheal tubes, intravenous and topical antibiotics, and oral decontamination methods.
• Dennis Maki, MD, evaluates controversial catheter maintenance to prevent bloodstream infections
• Jean Chastre, MD, compares the benefits and limitations of clinical strategies versus quantitative strategies in the diagnosis of VAP
• J. Victor Ryckman, MD, describes wound infections and protocols for preventio in surgical patients
• May Lou Sole, PhD, RN, CCNS, FAAN, explores the nurse’s role in infection prevention, the need for a team approach, educational integration, and the use of bundles

Guidelines

Guidelines for the management of intravascular catheter-related infections
Clin Inf Dis 2001;32:1249-1272

Guidelines for the prevention of intravascular catheter-related infections
MMWR 2002;1(RR-10):1-29

Publications

The ICU clinician is confronted on a regular basis with 2 conflicting goals of practice: 1) initiating effective antimicrobial therapy early to minimize infection-related morbidity and mortality, and 2) minimizing antimicrobial use to reduce the incidence of antimicrobial resistance. The most immediate consequences of flawed antimicrobial practices are the increased morbidity/mortality, superinfection with multi- or even pan-resistant organisms, serious toxicity, antibiotic-related colitis, and increased direct and in direct health care costs. Indeed, although there are now more approved antimicrobials than ever before, at many tertiary-care and academic centers fewer antimicrobial choices are "at the bedside" due to the rising incidence of multiresistant gram-positive and gram-negative organisms.



For more information on caring for the critically ill and injured patients, the publication Multiprofessional Critical Care Review Course is available for purchase from the Society of Critical Care Medicine. Click here for details or to add to your shopping cart.

SCCM Pod-62 Simple Measures Can Decrease Catheter-Related Bloodstream Infections
Peter Pronovost, MD, PhD, FCCM, discusses his article published in the December 28 issue of the New England Journal of Medicine, titled "An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU." Dr. Pronovost and researchers showed through this study that simple measures, such as hand washing, can have a dramatic effect in reducing bloodstream infections. They focused on improved teamwork between doctors, nurses and other intensive care unit professionals, collecting data from 103 Michigan hospitals for up to 18 months. The reference for this article is NEJM 2006 Volume 355, Number 26:2725-2732.

SCCM Pod-40 CCM: Initial Antimicrobial Treatment of MRSA
Marin Kollef, MD, professor of medicine in the department of pulmonary and critical care medicine at the Washington University School of Medicine and director of medical critical care at Barnes-Jewish Hospital, discusses his article in the August issue of Critical Care Medicine, "Methicillin-Resistant Staphylococcus aureus Sterile-Site Infection: The Importance of Appropriate Initial Antimicrobial Treatment." (Crit Care Med; 2006, 34(8):2069-2074)

SCCM Pod-32 CC: Catheter-Related Bloodstream Infections
Vera De Palo, MD, outlines several common questions healthcare professionals should consider to help prevent catheter-related bloodstream infections in the ICU. Her article "Catheter-Related Bloodstream Infections: Can We Make it Safer For Our Patients?" appears in the April issue of Critical Connections. Dr. DePalo is associate chief of medicine and director of critical care at Memorial Hospital of Rhode Island. She also is an associate professor of medicine at Brown Medical School. (Crit Conn 2006 Vol.5 No.2)